Neuroectodermal Tumors < Neuroendocrine Tumors < Neurofibroma

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 171.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000400 (????)		[Imaging and radioguided surgery of tumors NETs].
000662 (2013)		Simulation-based reconstruction of absolute activities from the (99m)Tc/(111)In dual-isotope SPECT/CT: phantom experiments and imaging of neuroendocrine tumors.
000685 (2012)		Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours.
000867 (2013)		The value of preoperative imaging in small bowel neuroendocrine tumors.
000911 (2012)		Patient-specific whole-body attenuation correction maps from a CT system for conjugate-view-based activity quantification: method development and evaluation.
000A92 (2013)		Utility of ¹¹¹indium-pentetreotide scintigraphy in patients with neuroendocrine tumors.
000B17 (2012)		One single-time-point kidney uptake from OctreoScan correlates with number of desintegrations measured over 72 hours and calculated for the 6.7 hours half-life nuclide (177)Lu.
000D25 (2012)		Gallium-68 somatostatin receptor PET/CT: is it time to replace (111)Indium DTPA octreotide for patients with neuroendocrine tumors?
000F63 (2012)		Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI.
001016 (????)		Detection of somatostatin receptor subtypes 2 and 5 by somatostatin receptor scintigraphy and immunohistochemistry: clinical implications in the diagnostic and therapeutic management of gastroenteropancreatic neuroendocrine tumors.
001017 (????)		Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms?
001101 (2011)		Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
001134 (2011)		Intra-arterial treatment with 90yttrium microspheres in treatment-refractory and unresectable liver metastases of neuroendocrine tumors and the use of 111in-octreotide scintigraphy in the evaluation of treatment response.
001379 (2011)		Incremental diagnostic value and impact on patient management of somatostatin receptor scintigraphy with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors.
001384 (2011)		Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.
001442 (2011)		Efficacy of adding high-dose In-111 octreotide therapy during Sandostatin treatment in patients with disseminated neuroendocrine tumors: clinical results of 14 patients.
001556 (2011)		[Somatostatin receptor endoradiotherapy of neuroendocrine tumors: experience in Hungarian patients].
001558 (2011)		Targeted radiotherapy with radiolabeled somatostatin analogs.
001559 (2011)		Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors.
001795 (????)		Somatostatin receptor imaging with (111)In-pentetreotide in gastro-intestinal tract and lung neuroendocrine tumors-Impact on targeted treatment.
001942 (2010)		177Lu-octreotate, alone or with radiosensitising chemotherapy, is safe in neuroendocrine tumour patients previously treated with high-activity 111In-octreotide.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Neuroendocrine Tumors" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Neuroendocrine Tumors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Neuroendocrine Tumors
}}

---

This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024